SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001159036-20-000043
Filing Date
2020-11-02
Accepted
2020-11-02 16:04:56
Documents
16
Period of Report
2020-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kq32020.htm   iXBRL 8-K 47761
2 EXHIBIT 99.1 ex991q320208-k.htm EX-99.1 169265
8 halozymea23.jpg GRAPHIC 701236
  Complete submission text file 0001159036-20-000043.txt   1316038

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20201102.xsd EX-101.SCH 4445
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20201102_cal.xml EX-101.CAL 620
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20201102_def.xml EX-101.DEF 1470
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20201102_lab.xml EX-101.LAB 26147
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20201102_pre.xml EX-101.PRE 13576
9 EXTRACTED XBRL INSTANCE DOCUMENT a8-kq32020_htm.xml XML 4542
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 201280468
SIC: 2836 Biological Products, (No Diagnostic Substances)